Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry

被引:15
|
作者
Proietti, Marco [1 ]
Airaksinen, K. E. Juhani [2 ,3 ]
Rubboli, Andrea [4 ]
Schlitt, Axel [5 ]
Kiviniemi, Tuomas [6 ]
Karjalainen, Pasi P. [7 ]
Lip, Gregory Y. H. [1 ,8 ]
机构
[1] Univ Birmingham, Inst Cardiovas Sci, Birmingham, W Midlands, England
[2] Turku Univ Hosp, Heart Ctr, Turku, Finland
[3] Univ Turku, Turku, Finland
[4] Osped Maggiore Bologna, Div Cardiol, Lab Intervent Cardiol, Bologna, Italy
[5] Martin Luther Univ Halle Wittenberg, Dept Med 3, Halle, Germany
[6] Paracelsus Harz Clin, Dept Cardiol, Bad Suderode, Germany
[7] Satakunta Cent Hosp, Heart Ctr, Pori, Finland
[8] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark
关键词
MYOCARDIAL-INFARCTION; ORAL ANTICOAGULATION; CLINICAL-OUTCOMES; TRIPLE THERAPY; MANAGEMENT; STROKE; RISK; CLOPIDOGREL; WARFARIN; DISEASE;
D O I
10.1016/j.ahj.2017.05.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Combination of oral anticoagulation (OAC) and antiplatelets is used in atrial fibrillation (AF) patients undergoing percutaneous coronary intervention and stent (PCI-S) procedure but is associated with increased bleeding when triple antithrombotic therapy (TAT) is used. Our aim was to analyze the impact of time in therapeutic range (TTR) on outcomes, in patients prescribed with TAT. Methods Ancillary analysis from the AFCAS registry in patients assigned to TAT. TTR was calculated with Rosendaal method. Outcomes were analyzed according to TTR tertiles (T1 [<= 56.8%] vs. T2 [56.9-93.8%] vs. T3 [<= 93.9%]). Major bleeding was the primary outcome. Results Of 963 patients enrolled, 470(48.8%) were prescribed with TAT at discharge and qualified for this analysis. Median [IQR] TTR was 80.0% [45.3-100%]. After 359 [341-370] days, major bleeding rates were progressively lower with increasing TTR tertiles (T1 vs. T2 vs. T3: 10.3% vs. 4.7% vs. 2.3%, P = .006). Kaplan-Meier analysis demonstrated a progressively lower risk for major bleeding across tertiles (P = .006). Patients in the highest TTR tertile had a non-significant lower risk for major adverse coronary and cerebrovascular events (MACCE) (log-rank: 4.905, P = .086). Cox regression analysis showed that T2 and T3 were inversely associated with major bleeding (hazard ratio [HR]:0.39, P = .050 and HR: 0.21, P = .005). Continuous TTR was inversely associated with major bleeding (HR: 0.98, P < .001). For MACCE, adjusted Cox analysis found a non-significant lower risk for T3 (HR: 0.64, P = .128). Conclusions In AF patients undergoing PCI-S prescribed TAT, good quality anticoagulation control (as reflected by TTR) was closely related to bleeding outcomes during follow-up. Despite some suggestive trends for an inverse relationship between TTR and MACCE, no definitive conclusions can be drawn, and further large studies are needed.
引用
收藏
页码:86 / 93
页数:8
相关论文
共 50 条
  • [31] Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry
    Marco Proietti
    K. E. Juhani Airaksinen
    Andrea Rubboli
    Axel Schlitt
    Tuomas Kiviniemi
    Pasi P. Karjalainen
    Gregory Y. H. Lip
    Clinical Research in Cardiology, 2017, 106 : 420 - 427
  • [32] One-Year Outcomes in Anticoagulated Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the Greek Antiplatelet Atrial Fibrillation Registry
    Alexopoulos, Dimitrios
    Dragona, Vassiliki-Maria
    Varlamos, Charalampos
    Ktenas, Dionysios
    Lianos, Ioannis
    Patsilinakos, Sotirios
    Sionis, Dimitrios
    Zarifis, Ioannis
    Bampali, Theodora
    Poulimenos, Leonidas
    Skalidis, Emmanouil
    Pissimisis, Evangelos
    Trikas, Athanasios
    Tsiafoutis, Ioannis
    Kafkas, Nickolaos
    Olympios, Christoforos
    Tziakas, Dimitrios
    Ziakas, Antonios
    Voudris, Vassilis
    Kanakakis, Ioannis
    Tsioufis, Costas
    Davlouros, Periklis
    Benetou, Despoina-Rafailia
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2023, 81 (02) : 141 - 149
  • [33] Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry
    Nammas, Wail
    Kiviniemi, Tuomas
    Schlitt, Axel
    Rubboli, Andrea
    Valencia, Jose
    Lip, Gregory Y. H.
    Karjalainen, Pasi P.
    Biancari, Fausto
    Airaksinen, K. E. Juhani
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 253 : 35 - 39
  • [34] Heparin Bridging vs. Uninterrupted Oral Anticoagulation in Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting - Results From the AFCAS Registry
    Lahtela, Heli
    Rubboli, Andrea
    Schlitt, Axel
    Karjalainen, Pasi P.
    Niemela, Matti
    Vikman, Saila
    Puurunen, Marja
    Weber, Michael
    Valencia, Jose
    Biancari, Fausto
    Lip, Gregory Y. H.
    Airaksinen, K. E. Juhani
    CIRCULATION JOURNAL, 2012, 76 (06) : 1363 - 1368
  • [35] Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting
    Caballero, Luis
    Ruiz-Nodar, Juan M.
    Marin, Francisco
    Roldan, Vanessa
    Hurtado, Jose A.
    Valencia, Jose
    Manzano-Fernandez, Sergio
    Sogorb, Francisco
    Valdes, Mariano
    Lip, Gregory Y. H.
    AGE AND AGEING, 2013, 42 (01) : 70 - 75
  • [36] Clinical usefulness of ATRIA score to predict cardiovascular outcomes in patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting
    Iwasaki, Y.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1296 - 1296
  • [37] Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting
    Ruiz Nodar, J. M.
    Marin, F.
    Caballero, L.
    Hurtado, J.
    Valencia, J.
    Manzano-Fernandez, S.
    Roldan, V.
    Valdes, M.
    Sogorb, F.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2010, 31 : 605 - 605
  • [38] Clinical usefulness of ORBIT score to predict cardiovascular outcomes in patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting
    Iwasaki, Y.
    Yamada, T.
    Morita, T.
    Furukawa, Y.
    Tamaki, S.
    Kawasaki, M.
    Kikuchi, A.
    Kondo, T.
    Ishimi, M.
    Hakui, H.
    Ozaki, T.
    Sato, Y.
    Seo, M.
    Fukunami, M.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1346 - 1346
  • [39] Effect of atrial fibrillation on angiographic characteristics and severity of coronary artery disease in patients undergoing percutaneous coronary intervention
    Biccire, Flavio Giuseppe
    Tanzilli, Gaetano
    Pignatelli, Pasquale
    Violi, Francesco
    Barilla, Francesco
    Gaudio, Carlo
    Pastori, Daniele
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N5 - N5
  • [40] OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ATRIAL FIBRILLATION
    Shanmugasundaram, Madhan
    Hashemzadeh, Mehrtash
    Movahed, Mohammad
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1024 - 1024